Homocysteine and cardiovascular disease: a review of the evidence (Q36892501)

16 August 2017

1 reference

title

Homocysteine and cardiovascular disease: a review of the evidence (English)

1 reference

16 August 2017

cardiovascular disease

1 reference

1

Anthony S Wierzbicki

1 reference

PubMed ID

17654449

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Diabetes and Vascular Disease Research

16 August 2017

1 reference

16 August 2017

4

1 reference

16 August 2017

2

1 reference

16 August 2017

143-150

1 reference

16 August 2017

Homocysteine metabolism

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Mechanisms of homocysteine-induced atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Vitamin Intervention For Stroke Prevention trial: an efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Folate therapy and in-stent restenosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine: role and implications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Effect of drugs on homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Drugs affecting homocysteine metabolism: impact on cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Antihypertensive treatment and homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Vitamin-B12 Status of Patients on Long-term Metformin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.033

21 January 2018

Identifiers

DOI

10.3132/DVDR.2007.033

1 reference

16 August 2017

1 reference

PubMed ID

17654449